SPOKANE, Wash.--(BUSINESS WIRE)--Researchers at Signature Genomic Laboratories recently published the first large-scale prospective study comparing the detection rate of chromosomal abnormalities—missing or extra pieces of DNA—by microarray analysis in prenatal cases to that of neonatal cases referred with a variety of clinical findings, including congenital anomalies.
